DiaMedica Therapeutics Inc

NASDAQ:DMAC 3:57:58 PM EDT

2.57

+0.04 (+1.58%)

4:00:14 PM EDT: $2.58 +0.01 (+0.39%)

DiaMedica Therapeutics Inc Stock, NASDAQ:DMAC

301 Carlson Parkway, Suite 210, Minneapolis, Minnesota 55305

United States of America

Phone: +1.763.496.5454

Number of Employees: 19

http://www.diamedica.com

Description

DiaMedica Therapeutics, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It develops the DM199 product candidate, which focuses on acute ischemic stroke (AIS) and chronic kidney disease (CKD). The company was founded by Wayne Lautt on January 21, 2000 and is headquartered in Minneapolis, MN.